Cite
Intralymphatic administration of liposome-encapsulated drugs to mice: possibility for suppression of the growth of tumor metastases in the lymph nodes.
MLA
Kaledin, V. I., et al. “Intralymphatic Administration of Liposome-Encapsulated Drugs to Mice: Possibility for Suppression of the Growth of Tumor Metastases in the Lymph Nodes.” Journal of the National Cancer Institute, vol. 66, no. 5, May 1981, pp. 881–87. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6939932&authtype=sso&custid=ns315887.
APA
Kaledin, V. I., Matienko, N. A., Nikolin, V. P., Gruntenko, Y. V., & Budker, V. G. (1981). Intralymphatic administration of liposome-encapsulated drugs to mice: possibility for suppression of the growth of tumor metastases in the lymph nodes. Journal of the National Cancer Institute, 66(5), 881–887.
Chicago
Kaledin, V I, N A Matienko, V P Nikolin, Y V Gruntenko, and V G Budker. 1981. “Intralymphatic Administration of Liposome-Encapsulated Drugs to Mice: Possibility for Suppression of the Growth of Tumor Metastases in the Lymph Nodes.” Journal of the National Cancer Institute 66 (5): 881–87. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=6939932&authtype=sso&custid=ns315887.